Kate Sheldon
Corporate Officer/Principal bei The Courtagen Group LLC
Profil
Dr. Kate Sheldon is a Director-Assay Development at The Courtagen Group LLC.
Prior to joining Courtagen, she was a Group Leader at BioScale, where she led the development of high sensitivity immunoassays for the detection of impurities in bioprocess samples.
Previously, she was with IDEXX Laboratories Inc., where she held a variety of scientific and management positions dedicated to the development of novel point of care solutions for the veterinary market.
Dr. Sheldon received a Bachelor’s degree in chemistry from Acadia University in Nova Scotia and Master’s and PhD degrees in biochemistry from The University of Toronto in Ontario.
Aktive Positionen von Kate Sheldon
| Unternehmen | Position | Beginn |
|---|---|---|
The Courtagen Group LLC
 The Courtagen Group LLC Investment ManagersFinance Courtagen Group LLC is a venture capital firm located in Charlestown, Massachusetts. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Kate Sheldon
| Unternehmen | Position | Ende |
|---|---|---|
| IDEXX LABORATORIES, INC. | Corporate Officer/Principal | - |
Courtagen Life Sciences, Inc.
 Courtagen Life Sciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA. | Corporate Officer/Principal | - |
ProterixBio, Inc.
 ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Corporate Officer/Principal | - |
Ausbildung von Kate Sheldon
| Acadia University | Undergraduate Degree |
| University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IDEXX LABORATORIES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Courtagen Group LLC
The Courtagen Group LLC Investment ManagersFinance Courtagen Group LLC is a venture capital firm located in Charlestown, Massachusetts. | Finance |
ProterixBio, Inc.
ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Health Technology |
Courtagen Life Sciences, Inc.
Courtagen Life Sciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Courtagen Life Sciences, Inc. provides proteomic and genomic products and services to the life sciences industry. It offers clinical genetic tests for developmental delay, intellectual disability, autism spectrum disorders, epilepsy and seizure disorders and mitochondrial disorders. The company was founded by Jocelyn W. Burke, Elizabeth Holland, Brendan L. McKernan, Kevin J. McKernan, Brian R. McKernan and Timothy Olcott in 1999 and is headquartered in Woburn, MA. | Electronic Technology |
